Mar, 2007
News / Press Releases
ASTELLAS LICENSES REGENERON'S VELOCIMMUNE® TECHNOLOGY FOR DISCOVERING HUMAN MONOCLONAL ANTIBODIES (pdf 22KB)
Read More
News / Press Releases
Astellas Announces Cancellation of Treasury Stock (pdf 24KB)
Read More
News / Press Releases
Astellas Assigns All Outstanding Shares of Its Production Subsidiary to Choseido (pdf 24KB)
Read More
News / Press Releases
Astellas Receives an FDA Action Letter for Prograf sNDA (pdf 27KB)
Read More
Apr, 2024
Apr, 2024
Feb, 2024
Nov, 2023
Mar, 2024
Feb, 2024
Oct, 2023
Sep, 2023
Nothing Found
Unfortunately, we weren't able to find a match for your search query. Please try again.
Nothing Found
Unfortunately, we weren't able to find a match.